Tetrabenazine for the Treatment of Hyperkinetic Movement Disorders: A Review of the Literature

This publication has 85 references indexed in Scilit:

• Update on the role of antipsychotics in the treatment of Tourette syndrome
  Neuropsychiatric Disease and Treatment, 2012
• Tetrabenazine
  CNS Drugs, 2011
• Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study
  PLoS Currents, 2011
• Vesicular monoamine transporters: Structure‐function, pharmacology, and medicinal chemistry
  Medicinal Research Reviews, 2011
• Management of Huntington’s disease: role of tetrabenazine
  Therapeutics and Clinical Risk Management, 2011
• Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
  Neuropsychiatric Disease and Treatment, 2010
• Advances in the Pharmacological Management of Huntingtonʼs Disease
  Drugs, 2010
• Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
  BMC Neurology, 2009
• Treatment strategies for dystonia
  Expert Opinion on Pharmacotherapy, 2009
• Tourettism associated with Huntington's disease
  Movement Disorders, 1995